In a randomized, double-blind, placebo- and active-controlled Phase 3 trial conducted in Europe and Australia (NCT00689104), mirabegron 50 mg and 100 mg resulted in statistically significant ...

Mirabegron had an annual sale of $2.42 billion in the US (both 25 mg and 50 mg), according to IQVIA data (IQVIA MAT February 2024). Follow our market blog for live updates The market is equally ...

Patients were also excluded from the study if they were taking any medications intended to treat OAB. There were no restrictions as to the number of antimuscarinic drugs that a patient could have ...